Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

The acquisition of global rights to NJO from Sanofi is expected to contribute positively to EBITDA from 2025 onwards. Recordati SpA (RICFY) reported a robust free cash flow of 434.3 million euros, up ...

On the way, it acquired Sanofi India's vaccine portfolio, which has helped it deliver double-digit domestic growth in the ...

Revenue for Emcure Pharma Q2 rose by over 20%, totaling ₹2,002 Crore, driven by strong performance across segments.

The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...

Fitch Solutions, an industry provider of credit and macro intelligence, has predicted that the naira would slide to as low as N1,993 per dollar in 2028 severely impacting the country’s pharmaceutical ...

Nigeria, the giant of Africa, has recently experienced a great downturn in its economy, leading to the exodus of several ...

BMI, a Fitch Solutions company, has predicted that the naira would slide to as low as N1,993 to one US dollar in 2028, ...

International attendees to the event told People's Daily that CIIE's upgrades and expansion created valuable opportunities ...

Emcure Pharmaceuticals (BSE:544210, NSE: EMCURE) today announced its unaudited consolidated financial results for the qu ...

BMI has predicted that naira will reach N1,993/$ by 2028, impacting Nigeria’s pharmaceutical industry’s ability to import ...

In September, commenced patient dosing to investigate evorpacept plus SARCLISA® (isatuximab-irfc) and dexamethasone in patients with relapsed or refractory multiple myeloma (RRMM) in the ...